Blog
RSS FeedPosted by Michael Wonder on 19 Dec 2019
Request for information on lamotrigine brand change
9 December 2019 - The request, dated 15 November 2019, asked for all and any advice or information or guidance that ...
Posted by Michael Wonder on 18 Dec 2019
Funding of vitamin A oral liquid
18 December 2019 - PHARMAC is pleased to announce that PHARMAC has approved the use of the Exceptional Circumstances framework ...
Posted by Michael Wonder on 18 Dec 2019
Proposal to fund mepolizumab for the treatment of severe refractory eosinophilic asthma
18 December 2019 - PHARMAC is seeking feedback on a proposal to fund mepolizumab (Nucala), a new treatment for severe ...
Posted by Michael Wonder on 17 Dec 2019
Comparison of PHARMAC with UK agency was misleading
17 December 2019 - The Broadcasting Standards Authority has upheld part of a complaint that an interview on Radio New ...
Posted by Michael Wonder on 17 Dec 2019
PHARMAC brand switch: man driving through Waterview Tunnel blacked out
18 December 2019 - An Auckland man had a seizure and blacked out as he drove through Auckland's Waterview Tunnel after ...
Posted by Michael Wonder on 17 Dec 2019
Calls for answers about PHARMAC delay after epilepsy deaths
17 December 2019 - The Opposition is calling for answers from the Government about why it took two weeks for ...
Posted by Michael Wonder on 17 Dec 2019
Lamotrigine NPPA change
17 December 2019 - The request seeks all ‘communications’ between members of the PHARMAC senior leadership team, and in anticipation ...
Posted by Michael Wonder on 16 Dec 2019
PHARMAC knew of epilepsy deaths for weeks but stayed silent
17 December 2019 - PHARMAC knew for more than two weeks that three deaths had been linked to its epilepsy ...
Posted by Michael Wonder on 16 Dec 2019
Proposal to widen funded access to lenalidomide for multiple myeloma
16 December 2019 - PHARMAC is seeking feedback on a proposal to widened funded access to lenalidomide (Revlimid) to include ...
Posted by Michael Wonder on 11 Dec 2019
Decision to award sole supply for apomorphine hydrochloride
11 December 2019 - PHARMAC are pleased to announce changes to the funding of apomorphine hydrochloride, a medicine used to ...
Posted by Michael Wonder on 09 Dec 2019
Proposals for funding in the blood, alimentary and immunosuppressant therapy areas
9 December 2019 - PHARMAC is seeking feedback on proposals to widen funded access to medicines in the blood, alimentary ...
Posted by Michael Wonder on 06 Dec 2019
PHARMAC says it welcomes a joint inquiry into four deaths - which have all been linked to the anti-epileptic drug, Logem
6 December 2019 - Chief Coroner Judge Deborah Marshall made the announcement today. ...
Posted by Michael Wonder on 05 Dec 2019
PHARMAC funded video downplays side effects of drug linked to four unexplained deaths, epilepsy patients say
5 December 2019 - Epilepsy patients are upset about a PHARMAC funded video which they say downplays the side effects of ...
Posted by Michael Wonder on 05 Dec 2019
PHARMAC announces faster assessment of cancer medicines
4 December 2019 - From 1 January 2020, PHARMAC will assess funding applications for new cancer medicines at the same ...
Posted by Michael Wonder on 05 Dec 2019
Decision to widen access to rituximab and award sole supply
5 December 2019 - PHARMAC has made a decision to make changes to the funding of rituximab, including widening access and ...